.ANALYSIS FEATURE.06 August 2024.
A huge randomized measured test along with cisgender women highlights the obstacles of faithfulness to a daily oral preexposure prophylaxis routine and also displays that twice-yearly treatment of lenacapavir can preserve successful HIV protection amounts over 6 months.